These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25704505)

  • 1. CA 19-9 in evaluation of adnexal mass: retrospective cohort analysis and review of the literature.
    Sagi-Dain L; Lavie O; Auslander R; Sagi S
    Int J Biol Markers; 2015 Jul; 30(3):e333-40. PubMed ID: 25704505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEA in evaluation of adnexal mass: retrospective cohort analysis and review of the literature.
    Sagi-Dain L; Lavie O; Auslander R; Sagi S
    Int J Biol Markers; 2015 Nov; 30(4):e394-400. PubMed ID: 26109367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
    Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
    J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of ultrasound features and the Risk of Ovarian Malignancy Algorithm score for different histopathological subtypes of benign adnexal masses.
    Ionescu CA; Matei A; Navolan D; Dimitriu M; Bohâltea R; Neacsu A; Ilinca C; Ples L
    Medicine (Baltimore); 2018 Aug; 97(31):e11762. PubMed ID: 30075600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy and cost-effectiveness of different strategies to triage women with adnexal masses: a prospective study.
    Piovano E; Cavallero C; Fuso L; Viora E; Ferrero A; Gregori G; Grillo C; Macchi C; Mengozzi G; Mitidieri M; Pagano E; Zola P
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):395-403. PubMed ID: 27706929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
    Bozkurt M; Yumru AE; Aral I
    Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian masses in children and adolescents - an analysis of 521 clinical cases.
    Zhang M; Jiang W; Li G; Xu C
    J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):e73-7. PubMed ID: 24157281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors].
    Smoleń A; Stachowicz N; Czekierowski A; Kotarski J
    Ginekol Pol; 2010 Apr; 81(4):254-61. PubMed ID: 20476596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Use and Optimal Cutoff Value of Ca15-3 in Evaluation of Adnexal Mass: Retrospective Cohort Study and Review of the Literature.
    Sagi-Dain L; Lavie O; Auslander R; Sagi S
    Am J Clin Oncol; 2018 Sep; 41(9):838-844. PubMed ID: 28338481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of adnexal masses with three-dimensional ultrasonography.
    Geomini PM; Kluivers KB; Moret E; Bremer GL; Kruitwagen RF; Mol BW
    Obstet Gynecol; 2006 Nov; 108(5):1167-75. PubMed ID: 17077239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors.
    Timmerman D; Van Calster B; Jurkovic D; Valentin L; Testa AC; Bernard JP; Van Holsbeke C; Van Huffel S; Vergote I; Bourne T
    J Clin Oncol; 2007 Sep; 25(27):4194-200. PubMed ID: 17698805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
    Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
    Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative serum vascular endothelial growth factor (VEGF) in ovarian masses.
    Tanir HM; Ozalp S; Yalcin OT; Colak O; Akcay A; Senses T
    Eur J Gynaecol Oncol; 2003; 24(3-4):271-4. PubMed ID: 12807238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.
    Valentin L; Jurkovic D; Van Calster B; Testa A; Van Holsbeke C; Bourne T; Vergote I; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2009 Sep; 34(3):345-54. PubMed ID: 19585547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonographic discrimination between benign and malignant adnexal masses in premenopause.
    Radosa MP; Vorwergk J; Fitzgerald J; Kaehler C; Schneider U; Camara O; Runnebaum IB; Schleußner E
    Ultraschall Med; 2014 Aug; 35(4):339-44. PubMed ID: 23775448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian fibroma/fibrothecoma: retrospective cohort study shows limited value of risk of malignancy index score.
    Numanoglu C; Kuru O; Sakinci M; Akbayır O; Ulker V
    Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):287-92. PubMed ID: 23611791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transvaginal color Doppler ultrasonography and CA-125 in suspicious adnexal masses.
    Alcázar JL; Errasti T; Zornoza A; Mínguez JA; Galán MJ
    Int J Gynaecol Obstet; 1999 Sep; 66(3):255-61. PubMed ID: 10580673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses.
    van den Akker PA; Zusterzeel PL; Aalders AL; Snijders MP; Samlal RA; Vollebergh JH; Kluivers KB; Massuger LF
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):422-5. PubMed ID: 21824712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.